Kathleen Warnecke
Direttore/Membro del Consiglio presso CONSTELLATION PHARMACEUTICALS, INC.
Posizioni attive di Kathleen Warnecke
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 15/07/2021 | - |
Storia della carriera di Kathleen Warnecke
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Kathleen Warnecke
- Esperienza
